U.s. fda grants de novo clearance for first and only artificial intelligence system for colonoscopy; medtronic launches gi genius™ intelligent endoscopy module

- the gi genius™ module assists physicians in detecting pre-cancerous growths; potentially addressing 19 million colonoscopies annually - transformative ai colorectal cancer prevention  platform expands medtronic capabilities in medical technology data analytics and insights dublin, april 12, 2021 /prnewswire/ -- medtronic plc (nyse:mdt), the global leader in medical technology, today announced the u.s. food and drug administration (fda) granted de novo clearance for gi genius™ intelligent endoscopy module in the united states. the gi genius module is the first and only commercially available computer-aided detection (cade) system using artificial intelligence (ai) to identify colorectal polyps.
MDT Ratings Summary
MDT Quant Ranking